H. pylori Antibiotic Resistance Genes

‍Helicobacter pylori (H. pylori) is a gram-negative, spiral-shaped bacterium that infects the stomach lining, leading to chronic gastritis, peptic ulcers, gastric carcinoma, and gastric lymphoma.  

Affecting up to 50% of the global population, it is one of the most common chronic bacterial infections worldwide, with higher prevalence in developing countries. 

Typically acquired in early childhood, H. pylori persists without treatment due to its unique features like flagella for motility and urease enzyme production, enabling survival in the stomach's acidic environment.  The bacterium’s high mutation and recombination rates contribute to its extensive strain diversity. 

Treatment typically includes a combination of proton pump inhibitors and antibiotics, but rising antibiotic resistance, particularly to clarithromycin, metronidazole, and levofloxacin, poses a significant challenge. 

This resistance has reduced the efficacy of standard H. pylori eradication therapies, necessitating the development of new treatment strategies, diagnostic methods, and potentially new antibiotics to combat resistant strains.

What is H. Pylori?  [8., 11.]

Helicobacter pylori (H. pylori) is a gram-negative, spiral-shaped bacterium that infects the stomach lining and is a common cause of chronic gastritis, peptic ulcers, gastric lymphoma, and gastric carcinoma. 

It affects up to 50% of the global population, with higher prevalence in developing countries.  It is one of the most common chronic bacterial infections worldwide.

H. pylori is typically acquired in early childhood and persists without treatment. 

It is able to survive in the harsh acidic environment of the stomach due to its unique features like flagella for motility and urease enzyme production.

Its genome exhibits high mutation and recombination rates, leading to extensive strain diversity.  [8., 13.] 

While many infected individuals remain asymptomatic, the bacteria can cause symptoms such as abdominal pain, nausea, vomiting, and dyspepsia once gastritis or peptic ulcer disease develops.   H. pylori infection causes chronic gastritis in all cases and increases the risk of peptic ulcers by 2-6 fold and gastric cancer by 2-6 fold compared to uninfected individuals.  [3., 8.] 

Transmission occurs through fecal-oral, oral-oral, and gastric-oral routes, with lower socioeconomic status being a significant risk factor.  

Diagnosis involves both non-invasive methods like urea breath tests and stool antigen tests, and invasive methods such as endoscopic biopsy. 

Treatment often includes a combination of proton pump inhibitors and antibiotics.  Antibiotic combination therapies like clarithromycin triple therapy or bismuth quadruple therapy may be used.  [3.]  

Early identification and treatment of H. pylori infections are crucial to prevent serious gastrointestinal diseases and potential malignancies.  Collaboration among healthcare professionals is essential for effective management and improved patient outcomes.

The Current Global Health Concerns Regarding H. Pylori Antibiotic Resistance

Antibiotic resistance against Helicobacter pylori has reached alarming levels globally, creating a significant challenge in effectively treating and eradicating H. pylori infections.  In 2017, the World Health Organization (WHO) designated clarithromycin-resistant Helicobacter pylori a high priority for antibiotic research and development.  [15.]

The situation involving antibiotic resistance against H. pylori involves the following: 

Increasing Resistance Rates 

Resistance of H. pylori to commonly used antibiotics like clarithromycin, metronidazole, levofloxacin, and even amoxicillin has been increasing in many countries and regions across the world.  [9., 12.]  This trend of rising antibiotic resistance is concerning.

Geographic Variations 

The prevalence and patterns of H. pylori antibiotic resistance exhibit substantial geographic variations, with some countries like Bulgaria, Belgium, Iran, and Taiwan showing high resistance rates to multiple antibiotics, while others like France and Spain have relatively stable resistance levels.  [2., 12.]

Impact on Eradication Therapy 

The increasing antibiotic resistance has dramatically reduced the efficacy of standard H. pylori eradication therapies, leading to higher treatment failure rates.  [7., 9.] 

Resistance to key antibiotics in the standard triple or quadruple regimens compromises their effectiveness.  [12.] 

Emergence of Multi-Drug Resistance (MDR)

The rise of MDR H. pylori strains resistant to multiple antibiotics further complicates eradication efforts and limits treatment options.  [7.] 

Consequences of Treatment Failure 

Unsuccessful H. pylori eradication due to antibiotic resistance can lead to persistent infections, increased risk of gastric cancer and other complications, and higher healthcare costs.  [7., 12.] 

The growing antibiotic resistance in H. pylori is a significant problem because it undermines our ability to effectively treat and eradicate this bacterial infection, which is a major risk factor for various gastric diseases, including peptic ulcers and gastric cancer. 

As resistance rates continue to rise, standard therapies become less effective, necessitating the development of new treatment strategies, diagnostic methods, and potentially new antibiotics to combat resistant H. pylori strains.

H. pylori Antibiotic Resistance Genes Mechanisms  [7.] 

Antibiotic resistance in H. pylori is primarily mediated by specific genetic mutations that confer resistance to commonly used antibiotics. 

These mechanisms can be broadly categorized into the following main types: mutations affecting nucleic acid synthesis, mutations in rRNA coding genes, mutations related to cell wall synthesis, mutations affecting bacterial efflux pump systems, and mutations affecting biofilm production.

Nucleic Acid Synthesis-Related Gene Mutations

Mutations in genes involved in nucleic acid synthesis, such as the rdxA and frxA genes, can lead to resistance against metronidazole and other nitroimidazole antibiotics.  

These mutations impair the ability of the antibiotics to generate reactive oxygen species, which are essential for their bactericidal activity. 

rRNA Coding Gene Mutations

Mutations in the 23S rRNA gene, particularly at positions 2142 and 2143, are associated with resistance to clarithromycin.  Examples include mutations at positions A2142G, A2142C, and A2143G, which cause high-level clarithromycin resistance.  [7.] 

These mutations interfere with the binding of the antibiotics to the bacterial ribosome, preventing their inhibitory effect on protein synthesis. 

Cell Wall Synthesis-Related Gene Mutations  [6.] 

Mutations in genes involved in cell wall synthesis, such as the pbp1 gene, can confer resistance to beta-lactam antibiotics like amoxicillin.  These mutations alter the target site of the antibiotics, reducing their ability to inhibit cell wall synthesis and ultimately leading to bacterial survival. 

Efflux Pump Systems

Mutations can activate efflux pump systems, reducing intracellular antibiotic concentrations and leading to multi-drug resistance (MDR).

Efflux pump genes such as hefA, associated with the RND family, play a significant role in this process.

Biofilm Formation

Genes like SpoT, fucT, jHp_1117, homD, and cagA are associated with biofilm formation in H. pylori, which contributes to antibiotic resistance.

Biofilms protect the bacteria from antibiotics, making eradication more difficult.

Overall, these mutations allow H. pylori to evade the effects of antibiotics, complicating treatment and necessitating more effective strategies and individualized treatments based on antimicrobial susceptibility testing.

Laboratory Testing for H. pylori Antibiotic Resistance Genes

Test Information, Sample Collection and Preparation  [10.] 

Testing for H. pylori antibiotic resistance genes is typically done from infected tissue samples, or in stool testing.   A gastric biopsy is an advanced procedure done in a clinical setting.  In contrast, a stool sample may be collected at home.  

Samples can be assessed for the presence of H. pylori antibiotic resistance genes via culture, which is a relatively time-consuming process.  Newer methods are available including PCR (polymerase chain reaction) and NGS (next-generation sequencing) to identify genetic markers of antibiotic resistance.  

Special preparation may be required prior to sample collection; it is essential to consult with the ordering provider prior to sample collection.  

An example of a stool test to assess for the presence of H. pylori antibiotic resistance can be found here.  

Interpretation of H. pylori Antibiotic Resistance Genes

Optimal Test Results for H. pylori Antibiotic Resistance Genes

Ideally, test results show no evidence of the presence of antibiotic resistance genes.  

Clinical Significance of H. pylori Antibiotic Resistance Genes

The presence of one or more antibiotic resistance genes on testing may indicate a need to design an alternate treatment plan for an individual with an H. pylori infection.  

Treatments for H. pylori Infection

Typical first-line eradication therapies may include medications such as clarithromycin, bismuth, amoxicillin, metronidazole, or tetracycline in combination, along with a PPI.

With the increase in antibiotic resistance demonstrated by H. pylori, scientists are exploring alternative methods of treating H. pylori including botanical therapies.  Some botanical remedies that have shown promise in treating H. pylori include:  

Garlic  [1., 14.] 

Garlic (Allium sativum) has anti-H. pylori effects due to its ability to suppress H. pylori's urease, an enzyme that allows H. pylori to survive in the harsh, acidic conditions of the stomach.

Garlic's ability to inhibit urease makes it useful for treating H. pylori infection and associated gastric ulcers.

Garlic contains allicin, ajoene, and diallyl sulfide which display antimicrobial and anti-inflammatory properties.  One article recommends a dosage of 400-1200 mg/day.  [1.] 

Cranberry  [1., 14.] 

Cranberry (Vaccinium macrocarpon) is also effective against H. pylori because of its ability to inhibit urease, which is important for H. pylori's survival in the acidic conditions of the stomach.

Oregano  [14.] 

Oregano has also shown an ability to inhibit urease.  

Green Tea  [1., 14.] 

Green tea contains polyphenolic compounds and catechins like epicatechin, epigallocatechin gallate.  It has also demonstrated an ability to inhibit urease as well as anti-inflammatory action.  

Turmeric  [1., 14.]

The curcumin in turmeric inhibits shikimate dehydrogenase and NF-κB activation.  It also suppresses inflammatory cytokines.

Other compounds such as olive, wormwood, peppermint, licorice, black seed, and various Chinese and Korean herbal therapies have also demonstrated an ability to eradicate H. pylori.  [1., 14.]  

Generally, a combination of therapies is recommended rather than relying on one antibiotic or herbal remedy.  

Biomarkers for Predicting H. pylori Antibiotic Resistance Genes

Specific Resistance-Associated Mutations as Biomarkers

Certain genetic mutations in H. pylori have been well-characterized and are known to confer resistance to specific antibiotics. These mutations can serve as biomarkers for predicting antibiotic resistance and informing treatment decisions. 

For example, mutations in the 23S rRNA gene, particularly at positions 2142 and 2143, are strongly associated with clarithromycin resistance and can be used as biomarkers for predicting resistance to this antibiotic. 

Metagenomic Sequencing for Resistance Profiling

With the advent of next-generation sequencing (NGS) technologies, metagenomic sequencing has emerged as a powerful tool for comprehensive resistance profiling in H. pylori. 

This approach involves sequencing the entire genome of the bacterial strain, enabling the identification of known and novel resistance-associated mutations, as well as the detection of other genetic determinants that may contribute to antibiotic resistance. 

Integration with Other Virulence Factors

In addition to antibiotic resistance genes, other virulence factors of H. pylori such as those involved in adherence, motility, and toxin production, can also influence the clinical outcome and treatment response. 

Integrating resistance biomarkers with these virulence factors may provide a more comprehensive approach to personalized treatment and management of H. pylori infections. 

FAQ: H. pylori Antibiotic Resistance Genes

What is H. pylori?

Helicobacter pylori (H. pylori) is a type of bacteria that infects the stomach lining and is a common cause of peptic ulcers and chronic gastritis.  It is also associated with an increased risk of stomach cancer.

How does H. pylori cause antibiotic resistance?

H. pylori can develop resistance to antibiotics through genetic mutations.  These mutations can alter the target sites of antibiotics, produce enzymes that inactivate antibiotics, or increase efflux mechanisms that pump antibiotics out of the bacterial cell.

Why is antibiotic resistance in H. pylori a concern?

Antibiotic resistance in H. pylori is a significant concern because it makes standard treatments less effective, leading to persistent infections, increased risk of complications, and the need for more complex and costly treatment regimens.

What are the common antibiotic resistance genes found in H. pylori?

Common antibiotic resistance genes in H. pylori include:  [7.] 

• 23S rRNA mutations: Associated with resistance to clarithromycin.

• gyrA mutations: Linked to resistance to fluoroquinolones.

• pbp1 mutations: Related to resistance to amoxicillin.

• rdxA and frxA mutations: Contribute to resistance to metronidazole.

How is antibiotic resistance in H. pylori detected?

Antibiotic resistance in H. pylori can be detected through various methods, including:

• Culture and sensitivity testing: growing the bacteria in the lab and testing antibiotics.

• Molecular testing: identifying specific resistance genes using PCR (polymerase chain reaction) and other genetic techniques.

What are the treatment options for antibiotic-resistant H. pylori infections?

Treatment options for antibiotic-resistant H. pylori infections include:

• Combination therapy: Using multiple antibiotics simultaneously to overcome resistance.

• Sequential therapy: Administering different antibiotics in a specific sequence.

• Tailored therapy: Customizing treatment based on the specific resistance profile of the H. pylori strain.

Can lifestyle changes help manage H. pylori infections?

While antibiotics are necessary to eradicate H. pylori, lifestyle changes can help manage symptoms and reduce the risk of complications.  These include:

• Eating a balanced diet: avoiding spicy, acidic, and fatty foods that can irritate the stomach.

• Avoiding excessive NSAID use: nonsteroidal anti-inflammatory drugs can exacerbate stomach irritation.

• Reducing stress: stress management techniques can help reduce symptoms of gastritis.

What can be done to prevent antibiotic resistance in H. pylori?

Preventing antibiotic resistance in H. pylori involves:

• Using antibiotics judiciously: avoiding unnecessary antibiotic use and completing prescribed courses.

• Monitoring resistance patterns: tracking resistance trends to inform treatment guidelines.

• Developing new treatments: researching and developing alternative therapies.

Order H. pylori Testing

Click here to compare testing options and order testing for H. pylori and antibiotic resistance.